Search
Close this search box.

ASTHMA STUDY

GSK 204959

clinical_trailas_cystic_fibrosis_western_australia

STUDY OUTLINE

The study aims to evaluate the use of an auto-injector for the subcutaneous administration of mepolizumab in people with severe asthma.
 
To find out if this trial is suitable for you please register below or contact our Clinical Trials Team at admin@resphealth.uwa.edu.au or phone 6151 0888.

ELIGIBILITY & REQUIREMENTS

  • Age 18 and above with a diagnosis of asthma.
  • Use of a daily asthma medication.
  • At least one flare up of your asthma in the last 12 months.

WHAT'S INVOLVED

  • You will be required to attend a monthly visit to Sir Charles Gairdner Hospital for approximately five months. You will also receive three injections of active study medication.

THIS CLINICAL TRIAL IS CURRENTLY CLOSED

Please register your interest for future clinical trials and we will contact you when a suitable trial becomes available.

Scroll to Top